Velmanase alfa Completed Phase 2 Trials for Alpha-Mannosidosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02998879Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis
NCT01681940Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis